Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
Autor: | Olufunmilayo A. Lesi, Manal Elsayed, Christian Kuschel, C W Spearman, Sharon J. Hutchinson, Ricardo Baptista-Leite, Jessica Howell, Jeffrey V. Lazarus, Maia Butsashvili, Mark W. Sonderup, Rosmawati Mohamed, Sigurdur Olafsson, Wangsheng Li, Tim Walker, Rifat Atun, Lisa Aufegger, Aneley Getahun, Mark Thursz, Saeed Hamid, Raquel Peck, Ellen 't Hoen, Radi Hammad, David Wilson, Tracy Swan, Annette H. Sohn, Margaret Hellard, Sophia Schroeder, Alisa Pedrana, Nick Scott |
---|---|
Přispěvatelé: | Veritati - Repositório Institucional da Universidade Católica Portuguesa |
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Economic growth
IMPACT HISTORICAL EPIDEMIOLOGY Review Article Health Services Accessibility Global Burden of Disease Organizational Case Studies 0302 clinical medicine disease elimination GLOBAL EPIDEMIOLOGY Sustainable Development Hepatitis B Investment (macroeconomics) Hepatitis C investment case organizational case studies 030220 oncology & carcinogenesis HCV Health Resources 030211 gastroenterology & hepatology Public Health Viral hepatitis medicine.medical_specialty Investment case Developing country Reviews World Health Organization Disease elimination Developing countries 03 medical and health sciences PEOPLE medicine Humans Hepatitis Sustainable development Hepatology Public health SELECT COUNTRIES HIV developing countries medicine.disease Organizational case studies Models Organizational Business hepatitis B INJECTING DRUG-USE hepatitis C C VIRUS-INFECTION SUBSTITUTION THERAPY |
Zdroj: | Liver International Repositório Científico de Acesso Aberto de Portugal Repositório Científico de Acesso Aberto de Portugal (RCAAP) instacron:RCAAP |
ISSN: | 1478-3231 1478-3223 |
Popis: | Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost‐effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (a) evidence‐gathering and planning; (b) implementation; and (c) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment and implementation strategies for other countries facing similar challenges and resource constraints. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |